Evidence map›Paper›PMID 35788259›Full record

ArticleChronic obstructive pulmonary diseases (Miami, Fla.)2022

High Prevalence of Suboptimal Peak Inspiratory Flow in Hospitalized Patients With COPD: A Real-world Study.

Donald A Mahler, Shaban Demirel, Ramon Hollander, Gokul Gopalan, Asif Shaikh, Cathy D Mahle, Jessica Elder, Curtis Morrison

Open access · diamondAbstract read
In one paragraph

Article in Chronic obstructive pulmonary diseases (Miami, Fla.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Observational
  3. Technical evaluation of TurbuhalerBMC pulmonary medicine · 2025
    Article
  4. Article
  5. Article
  6. Observational
  7. Article
  8. Article
  9. Article
  10. Clinical Implications of Peak Inspiratory Flow in COPD: Post Hoc Analyses of the TRONARTO Study.International journal of chronic obstructive pulmonary disease · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Donald A MahlerGeisel School of Medicine at Dartmouth, Hanover, New Hampshire, United States.
Shaban DemirelLegacy Research Institute, Portland, Oregon, United States.
Ramon HollanderLegacy Salmon Creek Medical Center, Vancouver, Washington, United States.
Gokul GopalanBoehringer Ingelheim Pharmaceuticals, Incorporated, Ridgefield, Connecticut, United States.
Asif ShaikhBoehringer Ingelheim Pharmaceuticals, Incorporated, Ridgefield, Connecticut, United States.
Cathy D MahleBoehringer Ingelheim Pharmaceuticals, Incorporated, Ridgefield, Connecticut, United States.
Jessica ElderBoehringer Ingelheim Pharmaceuticals, Incorporated, Ridgefield, Connecticut, United States.
Curtis MorrisonLegacy Salmon Creek Medical Center, Vancouver, Washington, United States.
Dartmouth College · USLegacy Health · US

Funding

Boehringer Ingelheim Pharmaceuticals
6 · The paper itself

Abstract

For optimal drug delivery, dry powder inhalers (DPIs) depend on the patient's peak inspiratory flow (PIF) and the internal resistance of the device to create turbulent energy and disaggregate the powder. A suboptimal PIF may lead to ineffective drug inhalation into the lungs. Our objective was to report the prevalence of suboptimal PIF in patients with COPD hospitalized for any reason using 1 or more DPIs. In this real-world, observational, single‑site, retrospective study, PIF was measured for each DPI using the In-Check™ DIAL set to match the resistance of the DPI used by each patient. PIFs <60 and <30L/min were considered suboptimal for low to medium-high- and high-resistance DPIs, respectively. At initial hospitalization, the prevalence of suboptimal PIF was 44.6% in 829 patients (mean age, 71.7 years; 56.8% female); 21.2% were measured during admission for a COPD exacerbation. Suboptimal PIF percentages were 61.0% (38.1±9.5L/min [mean±standard deviation (SD)]) across low to medium-high-resistance DPIs and 17.2% (20.7±4.2L/min) for high-resistance DPIs. Overall, 190/829 patients had 1 or more 30-day all-cause readmission with 253 corresponding PIF measurements. For readmissions, suboptimal PIFs were observed in 49.5% (94/190) of patients. Suboptimal PIF percentages were 65.4% (38.4±9.2L/min) for low to medium-high-resistance DPIs and 19.8% (22.4±3.3L/min) for high-resistance DPIs. As the overall prevalence of suboptimal PIFs in hospitalized patients with COPD varied according to the specific internal resistance of the DPI, these findings may have clinical implications for inhaler selection.

Indexed as

chronic obstructive pulmonary diseasedry powder inhalerpeak inspiratory flow

Identifiers

PMID35788259
PMCPMC9448011
OpenAlexW4283826600

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.